Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04139980 · ClinicalTrials.gov registry record · NA

Virtual Reality Device for Rehabilitation of Stroke Patients

A NA study of Stroke, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
5
Enrollment target
1
Study location

NCT04139980 is a NA study of Stroke that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 5 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04139980, a NA study of Stroke, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
5 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the potential efficacy and safety of using virtual reality gaming in conjunction to standard therapy regimen care as an approach to promote upper-limb motor recovery, cognitive function and quality of life after stroke. The investigators believe that allowing users to interact with a computer-simulated reality environment will result in a pleasant experience, which will likely result in motivation and therapy engagement.

Conditions Studied

Interventions

  • OTHER Virtual Reality (VR)

Study Locations (1)

Alabama

  • UAB Spain Rehabilitation Center - Birmingham

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2020-01-01
Est. Completion 2020-03-03
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT04139980

The ClinicalTrials.gov registry entry for NCT04139980 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Virtual Reality (VR) is the first listed.

NCT04139980 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT04139980 about?

NCT04139980 is a clinical study titled "Virtual Reality Device for Rehabilitation of Stroke Patients". This study will evaluate the potential efficacy and safety of using virtual reality gaming in conjunction to standard therapy regimen care as an approach to promote upper-limb motor recovery, cognitive function and quality of life after stroke. The investigators believe that allowing users to intera...

What is the current status of trial NCT04139980?

This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2020-01-01. Estimated completion is 2020-03-03.

What conditions does trial NCT04139980 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT04139980?

The interventions under investigation include: Virtual Reality (VR) (OTHER).

Who is sponsoring clinical trial NCT04139980?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04139980 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.